[Clinical guidelines for the management of schizophrenia: Pharmacological and psychological interventions (III)].

[Clinical guidelines for the management of schizophrenia: Pharmacological and psychological interventions (III)]. Psychiatriki. 2018 Oct-Dec;29(4):303-315 Authors: Hadjulis M, Margariti M, Lazaridou M, Angelidis GF, Fotopoulos V, Markaki L, Koulouri F Abstract In 2014 a Working Group was set up by the Greek Ministry of Health, with the objective of formulating Clinical Guidelines for the management of schizophrenia which include recommendations for the pharmacological and the psychosocial treatment of schizophrenia. This Working Group utilized the NICE Guideline (National Institute of Clinical Excellence 2014) for the management of Psychosis & Schizophrenia as the main guide in the development of the Greek guidelines, and in addition the American Psychiatric Association (APA) Practice Guideline for the Treatment of Patients with Schizophrenia (APA, 2004), the Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders (Royal Australian and New Zealand College of Psychiatrists 2005), as well as other relevant sources. Furthermore, the Hellenic Psychiatric Association (HPA) established an Expert Committee that contributed with its observations to this exercise. With regard to the pharmacological management of schizophrenia, recommendations for initiating and monitoring drug therapy, treating the first psychotic episode as well as treating the acute ...
Source: Psychiatriki - Category: Psychiatry Tags: Psychiatriki Source Type: research